PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: single-center real-world experience: A.L. Faccini, M. Biglietto, S. Sorella, E. Crisanti, M. Antonacci, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro, S. Ligia | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy. Bleeding, Thrombosis and Vascular Biology, [S. l.], v. 4, n. s1, 2025. DOI: 10.4081/btvb.2025.355. Disponível em: https://www.btvb.org/btvb/article/view/355. Acesso em: 6 aug. 2025.